5-Amino-1MQ Research Overview: NNMT Inhibition, Metabolic Signaling & Cellular Energy

What Is 5-Amino-1MQ?

5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small-molecule research compound investigated for its role as a selective inhibitor of nicotinamide N-methyltransferase (NNMT) — an enzyme that plays a central regulatory role in cellular metabolism, energy homeostasis, and adipogenesis. As interest in metabolic signaling research expands, 5-Amino-1MQ has emerged as a significant tool for studying how NNMT activity influences fat cell biology, NAD+ metabolism, and related biochemical pathways.

NNMT Inhibition and Metabolic Research

NNMT is highly expressed in adipose tissue and has been identified as a key regulator of the methylation cycle and NAD+ biosynthesis. By methylating nicotinamide, NNMT effectively reduces the availability of methyl donors and NAD+ precursors — impacting downstream signaling through pathways including SIRT1 and AMPK, which are closely associated with energy expenditure and metabolic homeostasis.

In preclinical models, selective inhibition of NNMT with compounds such as 5-Amino-1MQ has been explored for its potential to influence:

• Adipocyte differentiation and lipid accumulation — Experimental data suggest NNMT inhibition may reduce fat cell formation in vitro
• NAD+ and SAM availability — Blocking NNMT activity may restore methyl donor pools and support NAD+-dependent metabolic signaling
• Resting metabolic rate — Animal studies have examined whether NNMT inhibition influences energy expenditure without changes to caloric intake
• Obesity and diet-induced metabolic dysfunction — Preclinical models using high-fat diet protocols have incorporated NNMT inhibitors to study metabolic outcomes

Role in NAD+ and Epigenetic Signaling Research

One of the most compelling aspects of 5-Amino-1MQ as a research compound is its position at the intersection of NAD+ metabolism and epigenetic regulation. NNMT consumes S-adenosylmethionine (SAM) — the cell's primary methyl donor — in the process of methylating nicotinamide. By inhibiting this reaction, 5-Amino-1MQ research models can examine how restoring SAM and NAD+ precursor availability affects histone methylation, gene expression, and sirtuin activity.

This makes it a relevant compound for laboratories studying the molecular overlap between metabolic disease, cellular aging, and epigenetic signaling pathways.

Research Compound Specifications

Parameter	Specification
Full Name	5-Amino-1-methylquinolinium
Compound Class	Small molecule NNMT inhibitor
Primary Research Target	Nicotinamide N-methyltransferase (NNMT)
Related Pathways	NAD+ metabolism, SAM cycle, SIRT1, AMPK signaling
Form	Lyophilized powder
Purity	≥98% (HPLC verified)
Storage	−20°C, protect from light and moisture
Application	Research use only — not for human or veterinary use

Current Areas of Experimental Investigation

• Adipogenesis and fat cell biology — In vitro models studying NNMT's role in lipid accumulation and adipocyte differentiation
• Metabolic rate and energy expenditure — Animal studies examining the relationship between NNMT inhibition and resting metabolic activity
• NAD+ pathway modulation — Research into how NNMT inhibition affects downstream sirtuin and AMPK signaling
• Epigenetic and methylation research — Investigations into SAM availability and its effects on histone methylation and gene regulation
• Diet-induced obesity models — Preclinical studies incorporating 5-Amino-1MQ into high-fat diet protocols to study metabolic outcomes

5-Amino-1MQ is supplied strictly as a research compound for laboratory and scientific investigation only. Not approved for human consumption, clinical application, or diagnostic purposes. All experimentation should be conducted by qualified professionals in appropriate research settings.